Infliximab Reduces Myeloperoxidase Concentration in Chronic Inflammatory Joint Diseases

Publisher： Karger

E-ISSN： 1423-0313|83|4|211-216

ISSN： 0031-7012

Source： Pharmacology, Vol.83, Iss.4, 2009-02, pp. : 211-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelial Dysfunction in Chronic Inflammatory Diseases

By Steyers Curtis M. Miller Francis J.

International Journal of Molecular Sciences, Vol. 15, Iss. 7, 2014-06 ,pp. : 11324-11349

MDPI

Access to resources Recommend Favorite

Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases

By Hristodorov Dmitrij Mladenov Radoslav Huhn Michael Barth Stefan Thepen Theo

Toxins, Vol. 4, Iss. 9, 2012-09 ,pp. : 676-694

MDPI

Access to resources Recommend Favorite

Dendritic Cell-Airway Epithelial Cell Cross-Talk Changes with Age and Contributes to Chronic Lung Inflammatory Diseases in the Elderly

By Agrawal Anshu

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1206-1206

MDPI

Access to resources Recommend Favorite

IL-18 and Cutaneous Inflammatory Diseases

By Lee Ji hyun Cho Dae Ho Park Hyun Jeong

International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-12 ,pp. : 29357-29369

MDPI

Access to resources Recommend Favorite

Application of Prodrugs to Inflammatory Diseases of the Gut

By Oz Helieh S. Ebersole Jeffrey L.

Molecules, Vol. 13, Iss. 2, 2008-02 ,pp. : 452-474

MDPI

Access to resources Recommend Favorite